We are pleased to invite you to Medicon Valley Alliance in Ørestad City, Copenhagen, Denmark, for a half-day event on The Road to China.
As the Chinese Life Science industry undergoes major changes, new business opportunities arise for Medicon Valley Life Science companies. This seminar aims to highlight these business opportunities and will give participants an insight into the commercial opportunities for pharma, biotech and medtech on the Chinese market. The seminar will provide presentations and discussions on:
- The market development trends and commercial opportunities within pharma, biotech and medtech on the Chinese market
- The identification and evaluation of commercial partners and investors for China related deals
- Contracting with Chinese partners
- The protection of IP when out-licensing technologies to Chinese partners
Date: 10 October 2013
Time: 8:30 – 13:45
Venue: Medicon Valley Alliance
Address: Arne Jacobsens Allé 15, DK- 2300 Copenhagen S
For members: Free of charge (late cancellation*/no-show fee DKK 500 ex VAT)
For non-members: Free of charge (late cancellation*/no-show fee DKK 500 ex VAT)
Registration ends 7 October 2013.
* If you cancel after the registration ends, it is considered late cancellation.
08.30-09.00 Coffee and networking
09.00-09.45 The pharmaceutical and medtech market in China today
/Frank Yu, Co-Founder and CEO of Themes Investment Management Ltd.
View the presentation here.
09.45-10.30 The Road to China
/Julian Thurston, CEO at Crescendo Enterprises. View the presentation here.
10.30-11.00 Networking, coffee and croissant
11.00-12.00 Proactiveness is Key in China
/Camilla Rendal Nielsen, Senior Partner at Zacco & Martin Sick-Nielsen, Senior Partner
at Zacco. View the presentation here.
12.00-12.45 IP enforcement in China
/Kan Zu, Attorney at Law, Vice President and Partner at Unitalen. View the presentation here.
12.45-13.45 Lunch and networking
This Boost Seminar is in collaboration with Crescendo and Zacco
The pharmaceutical and medtech market in China today
Frank is Co-Founder and CEO of Themes Investment Management Ltd which is a fund headquartered in Hong Kong specialising in cross-border investments in the devices and pharmaceutical sectors. Prior to founding Themes in 2010 Frank was a managing director of New York-based hedge fund Och-Ziff Capital.
The Road to China
Julian has been closely connected with the lifescience sector in the UK and Europe for over 30 years. He has specialised as an international lawyer advising on commercial transactions in the pharmaceutical, medical device and diagnostic sectors. His particular focus has been on all forms of commercial transactions and deals, including licensing and collaboration deals, deals for the acquisition of rights to products and technologies, all forms of joint ventures and other strategic partnering, and other commercial arrangements such as distribution, CMO and CRO arrangements.
He has built a significant reputation for carrying out these deals as a lawyer and, notably, in one of the most prestigious guides to lawyers and law firms, Chambers Global, he has been ranked one of the top 5 lawyers in the world for this specialism for each of the past 6 years.
For several years now, SME’s in UK and Europe focused on conducting research and development of products and technologies in the pharmaceutical, medical device and diagnostic areas have been suffering because of the steep decline in sources and availability of finance for their businesses.
With his involvement in the sector Julian spotted this trend early, along with the rapid growth of the pharmaceutical markets in the BRIC countries and other emerging markets. Because of this, about 5 years ago he decided to spend time and energy focusing on building networks of pharmaceutical, device and diagnostic companies and investors in China, Latin America, Russia and other emerging markets. The networks that he has built are unique.